// App-Quantinova.ai

D38 : CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute Kidney Allograft Rejection.

Researchers

Presenter

  • L. Schiffer

Principal Investigators

  • F. Wiehler

  • M. Daemmrich

  • K. Hueper

  • M. Mengel

  • A. Thorenz

  • S. von Vietinghoff

  • R. Song

  • M. Schiffer

  • F. Gueler

Medical Centers

  • Hannover Medical School, Hannover, Germany

  • Hannover Medical School, Hannover, Germany

  • Hannover Medical School, Hannover, Germany

  • Laboratory Medicine &amp

  • Hepatology, University of Alberta, Edmonton, Alberta, Canada

Locations

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Other

Disease

  • N/A

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 2AP

  • C-X-C Motif Chemokine Ligand 13

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved